Respiratory Syncytial Virus Vaccination Is Associated With Increased Odds of Preterm Birth
Acta Paediatrica · 2026
DOI: 10.1111/apa.17595 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Paediatrica, 2026. Verfasst von Ilari Kuitunen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine and Kuopio Pediatric Research Unit (KUPRU), University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Premature Birth, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Vaccination. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lastentautien Tutkimussäätiö, Suomen Kulttuurirahasto, Orionin Tutkimussäätiö.
Abstract (Originalsprache)
Aim
To analyse whether respiratory syncytial virus (RSV) vaccination during pregnancy increases the odds of preterm birth.
Methods
A rapid review and meta‐analysis was performed. The main outcome was the risk of preterm (gestational week less than 37) birth. A fixed‐effects model was used to analyse pooled odds ratios (OR) with 95% confidence intervals (CI). Evidence certainty was assessed according to GRADE.
Results
We included six randomised controlled trials with 17 656 births and two observational studies with 3446 births. The odds for preterm birth were increased in the randomised studies (OR 1.17, CI 1.02–1.34). No evidence of a difference was seen in the observational studies (OR 0.93, CI 0.69–1.25). Combined, these showed increased odds for preterm birth (OR 1.13, CI 1.00–1.27). Evidence certainty was rated to be moderate. When restricted to market‐approved vaccine, the odds seemed to be increased in RCTs (OR 1.21, CI 0.98–1.49).
Conclusion
Based on the available evidence, RSV vaccination seems to be associated with increased odds for preterm birth. RSV vaccination needs continuous population‐level observational safety data monitoring on the perinatal outcomes during the early phases of vaccine rollouts to detect possible safety signals and further confirm the magnitude of the effect on preterm birth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medicine and Kuopio Pediatric Research Unit (KUPRU), University of Eastern Finland, Kuopio, Finland.
- Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland.
- Department of Obstetrics, Mikkeli Central Hospital, Mikkeli, Finland.
ORCID-Profile: Ilari Kuitunen
Förderung
- Lastentautien Tutkimussäätiö
- Suomen Kulttuurirahasto
- Orionin Tutkimussäätiö
Zitieren
APA
Kuitunen, I., & Haapanen, M. (2026). Respiratory Syncytial Virus Vaccination Is Associated With Increased Odds of Preterm Birth. Acta Paediatrica. https://doi.org/10.1111/apa.17595
Vancouver
Kuitunen I, Haapanen M. Respiratory Syncytial Virus Vaccination Is Associated With Increased Odds of Preterm Birth. Acta Paediatrica. 2026. doi:10.1111/apa.17595
BibTeX
@article{Kuitunen2026,
author = {Kuitunen, Ilari and Haapanen, Marjut},
title = {Respiratory Syncytial Virus Vaccination Is Associated With Increased Odds of Preterm Birth},
journal = {Acta Paediatrica},
year = {2026},
doi = {10.1111/apa.17595}
}
EUVIMED